Calvin Knowlton, BScPharm, MDiv, PhD 鈥�93 - Honorary Doctor of Sciences
Calvin Knowlton has been a leader in the fields of pharmacy, business, and philanthropy for more than 30 years. He has founded 10 companies including Tabula Rasa HealthCare, Inc., and its subsidiary, CareKinesis, Inc.
Tabula Rasa develops technology-enabled products and services for medication risk management and organizational performance optimization, and CareKinesis provides medication therapy management to individuals with complex medication needs. Knowlton also founded excelleRx/Hospice Pharmacia in 1995, the first national pharmacy company devoted to hospice care. During his 12-year tenure as CEO, the company served 40 percent of all hospice patients in the United States.
Put more simply, Knowlton 鈥渋s the father of palliative pharmacotherapy,鈥� said 91大神 School of Pharmacy (UMSOP) Dean Natalie D. Eddington, PhD, FAAPS, FCP. 鈥淒r. Knowlton was gifted with the passion and vision to develop processes to optimize the appropriate use of medications at the end of life. The pharmaceutical care processes implemented in his practice and used to care for terminally ill patients have been recognized worldwide as models of excellence.
鈥淗is drive to change the way prescription medication is deployed continues to improve the quality of many individuals鈥� lives and will have a significant impact on the future of palliative pharmacotherapy.鈥�
Knowlton earned his PhD in pharmacoeconomics from UMSOP in 1993 and was honored as one of UMSOP鈥檚 Founding Pharmapreneurs in 2017. He has won several awards for innovation and leadership, including Most Influential Pharmacist in the U.S. in 1997, Ernst and Young Entrepreneur of the Year (Greater Philadelphia Region) in 2003 and 2013, and Walter M. Aikman Entrepreneur of the Year in 2004.
In 2015, he received the Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association (APhA), in recognition of his professional achievements, innovations, and advancements. He also has served as president of APhA, the APhA Foundation, and the American College of Apothecaries.
Knowlton received his pharmacy degree from Temple University and his divinity degree from Princeton Theological Seminary. He was a professor and department chair for the University of the Sciences in Philadelphia in the 1990s and has authored or co-authored textbooks, book chapters, and articles focused on the role and responsibility of pharmacists in the outcomes of patient-centered medication care.